| Literature DB >> 28391412 |
Bo Cao1, Xin Zhou1, Jiaojiao Ma2, Wei Zhou2, Wanli Yang2, Daiming Fan2, Liu Hong3.
Abstract
Inflammatory bowel diseases (IBD), mainly including Crohn's disease and ulcerative colitis, are characterized by chronic inflammation of the gastrointestinal tract. Despite improvements in detection, drug treatment and surgery, the pathogenesis of IBD has not been clarified. A number of miRNAs have been found to be involved in the initiation, development and progression of IBD, and they may have the potential to be used as biomarkers and therapeutic targets. Here, we have summarized the recent advances about the roles of miRNAs in IBD and analyzed the contribution of miRNAs to general diagnosis, differential diagnosis and activity judgment of IBD. Furthermore, we have also elaborated the promising role of miRNAs in IBD-related cancer prevention and prognosis prediction.Entities:
Keywords: Autophagy; Diagnosis; Immune homeostasis; Inflammatory bowel diseases; Intestinal epithelial barrier; MiRNA
Mesh:
Substances:
Year: 2017 PMID: 28391412 DOI: 10.1007/s10620-017-4567-1
Source DB: PubMed Journal: Dig Dis Sci ISSN: 0163-2116 Impact factor: 3.199